CB50091-21 - 0x0000000000006CDF
Males & Females of Non-Childbearing Potential
Energize
* Stipend may pay up to reflected amount.
Start Date:
May 9, 2026 - 2:00pm
End Date:
May 21, 2026 - 8:00am
Study Details
Study Number: CB50091
Group Number: 21
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,750.00
Study Criteria
Age: 19 - 59
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat leukemia
Route of Administration: Oral
Blood Draws: 37
Study Schedule
Schedule Type: Long Term
Study Length: 12 Night Stay
Screening Dates:
| Event Day | Event Date |
|---|---|
| Monday | 4/27/2026 |
| Tuesday | 4/28/2026 |
| Thursday | 4/30/2026 |
| Monday | 5/4/2026 |
| Tuesday | 5/5/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Monday | 4/27/2026 |
| Tuesday | 4/28/2026 |
| Thursday | 4/30/2026 |
| Monday | 5/4/2026 |
| Tuesday | 5/5/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Saturday | 5/9/2026 2:00:00 PM | Thursday | 5/21/2026 8:00:00 AM | 1 | Lincoln |
